← Back to Search

Essential Oil

Clary Sage Massage Oil for Quality of Life

N/A
Waitlist Available
Research Sponsored by Franklin School of Integrative Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pregnancy week 27 and 36

Summary

This trial is testing whether clary sage oil can help support health, wellbeing, and quality of life during pregnancy.

Eligible Conditions
  • Quality of Life
  • Pregnancy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pregnancy week 27 and 36
This trial's timeline: 3 weeks for screening, Varies for treatment, and pregnancy week 27 and 36 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in quality of life from week 27 to 36 of the pregnancy using the World Health Organization's Quality of Life, Brief-Form Scale (WHOQOL-BREF).
Change in salivary estriol levels from pregnancy week 27 to pregnancy week 36.
Secondary study objectives
Duration of Pregnancy
Duration of phase 2 of labor

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
Participants in this group will receive a fragrant plant based massage oil with the addition of clary sage essential oil. The massage oil will be massaged into the upper thighs daily for the duration of the third trimester.
Group II: ControlPlacebo Group1 Intervention
Participants in this group will receive a fragrant plant based massage oil. The massage oil will be massaged into the upper thighs daily for the duration of the third trimester.

Find a Location

Who is running the clinical trial?

Franklin School of Integrative Health SciencesLead Sponsor
11 Previous Clinical Trials
2,693 Total Patients Enrolled
Franklin Health ResearchLead Sponsor
16 Previous Clinical Trials
3,459 Total Patients Enrolled
~12 spots leftby Nov 2025